[DISCLOSURE] Ilyang Pharmaceutical (007570) reported on July 26 that its second-quarter operating profit rose 66.8 percent to 4.21 billion won (US$3.71 million) from the same period last year. Its sales dropped 9.6 percent to 61.6 billion won while net profit turned to black with 2.7 billion won.